Related Experiment Video
Updated: Feb 24, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Noninfective endocarditis in microscopic polyangiitis: Report of a case with a successful response to
Carolina Muñoz-Grajales1, Juan C Chavarriaga2, Javier D Márquez1
1Departamento de Reumatología, Hospital Pablo Tobón Uribe, Medellín, Colombia.
Abstract:
Although antineutrophil cytoplasmic antibody (ANCA) vasculitis has a variety of clinical manifestations, valvular compromise is not common, especially in anti-myeloperoxidase (anti-MPO) antibody (perinuclear [P]-ANCA) vasculitis. We report the case of a 38-year-old woman with ANCA-associated vasculitis who was diagnosed with valve vegetation, that resolved with immunosuppressive therapy.
Insights
Antineutrophil cytoplasmic antibody (ANCA) vasculitis rarely affects heart valves. This case shows valve vegetation in anti-myeloperoxidase (anti-MPO) vasculitis resolved with immunosuppressive therapy.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Antineutrophil cytoplasmic antibody (ANCA) vasculitis encompasses a group of systemic autoimmune diseases.
- While ANCA vasculitis can present with diverse clinical features, cardiac valvular compromise is an infrequent manifestation.
- Anti-myeloperoxidase (anti-MPO) antibody-associated vasculitis, a subtype of ANCA vasculitis, is particularly noted for its rarity of valvular involvement.
Observation:
- A 38-year-old woman with diagnosed ANCA-associated vasculitis presented with unusual valvular compromise.
- The patient exhibited findings consistent with valve vegetation, a serious cardiac condition.
- This presentation was specifically associated with anti-myeloperoxidase (anti-MPO) antibody positivity.
Findings:
- The valvular vegetation observed in the patient with anti-MPO ANCA vasculitis demonstrated a positive response to treatment.
- Successful resolution of the valve vegetation was achieved through immunosuppressive therapy.
- This suggests a potential pathogenic role for inflammation in the development of valvular lesions in this vasculitis subset.
Implications:
- This case expands the spectrum of clinical manifestations of ANCA-associated vasculitis, particularly anti-MPO vasculitis.
- It highlights the importance of considering cardiac valvular involvement in ANCA vasculitis patients, even when rare.
- The resolution of valvular vegetation with immunosuppression underscores the potential efficacy of targeted therapy for this uncommon complication.
Related Concept Videos
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
